Arich Enterprise Co Ltd (4173) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Arich Enterprise Co Ltd (4173) has a cash flow conversion efficiency ratio of -0.126x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$-252.67 Million ≈ $-7.96 Million USD) by net assets (NT$2.01 Billion ≈ $63.37 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Arich Enterprise Co Ltd balance sheet independence to measure how much of total assets are equity-financed.
Arich Enterprise Co Ltd - Cash Flow Conversion Efficiency Trend (2017–2025)
This chart illustrates how Arich Enterprise Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Arich Enterprise Co Ltd (4173) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Arich Enterprise Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Arich Enterprise Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Taekyung Chem
KO:006890
|
0.014x |
|
Hana Must SPAC 2
KQ:208370
|
0.013x |
|
Infrea AB
ST:INFREA
|
-0.046x |
|
Canlan Ice Sports Corp.
TO:ICE
|
0.085x |
|
Mercer International Inc
F:AEZ
|
0.678x |
|
Wisher Industrial Co Ltd
TW:1465
|
-0.178x |
|
Moorim Paper
KO:009200
|
-0.006x |
|
Cryosite Ltd
AU:CTE
|
0.361x |
Annual Cash Flow Conversion Efficiency for Arich Enterprise Co Ltd (2017–2025)
The table below shows the annual cash flow conversion efficiency of Arich Enterprise Co Ltd from 2017 to 2025. For the full company profile with market capitalisation and key ratios, see 4173 market cap overview.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | NT$2.01 Billion ≈ $63.37 Million |
NT$-1.90 Billion ≈ $-59.97 Million |
-0.946x | -184.55% |
| 2024-12-31 | NT$1.92 Billion ≈ $60.52 Million |
NT$2.15 Billion ≈ $67.74 Million |
1.119x | +924.86% |
| 2023-12-31 | NT$2.02 Billion ≈ $63.72 Million |
NT$-274.45 Million ≈ $-8.65 Million |
-0.136x | -283.42% |
| 2022-12-31 | NT$1.88 Billion ≈ $59.29 Million |
NT$139.23 Million ≈ $4.39 Million |
0.074x | -59.98% |
| 2021-12-31 | NT$1.82 Billion ≈ $57.28 Million |
NT$336.06 Million ≈ $10.59 Million |
0.185x | -41.17% |
| 2020-12-31 | NT$1.78 Billion ≈ $56.10 Million |
NT$559.56 Million ≈ $17.63 Million |
0.314x | -29.70% |
| 2019-12-31 | NT$1.26 Billion ≈ $39.78 Million |
NT$564.44 Million ≈ $17.78 Million |
0.447x | +331.77% |
| 2018-12-31 | NT$1.21 Billion ≈ $38.09 Million |
NT$-233.19 Million ≈ $-7.35 Million |
-0.193x | +67.55% |
| 2017-12-31 | NT$1.05 Billion ≈ $33.23 Million |
NT$-626.72 Million ≈ $-19.75 Million |
-0.594x | -- |
About Arich Enterprise Co Ltd
Arich Enterprise Co., Ltd. engages in the marketing, promotion, and distribution of pharmaceuticals in Taiwan. It offers sales promotion for pharmaceutical products; warehousing and logistics, and processing services. The company provides distribution and logistics services, including assists manufacturers with bidding processes; inventory management, order processing, invoicing, goods delivery, … Read more